Global DNA microarray market to grow at 7% CAGR, reaching $4.7B by 2034 driven by genomics and personalized medicine.

The global DNA microarray market is projected to grow at a compound annual growth rate (CAGR) of approximately 7% from 2026 to 2034, reaching a market size of $4.7 billion by 2034. This growth is fueled by increasing demand for advanced genomic research, personalized medicine, and early disease diagnosis, especially due to rising cases of cancer, genetic disorders, and infectious diseases. Technological advancements in bioinformatics, automation, and high-throughput screening, along with growing investments in biotechnology and pharmaceutical R&D, are further driving market expansion. North America currently leads the market, supported by strong healthcare infrastructure and government funding, while Asia-Pacific and Europe are also significant contributors due to improving healthcare and research capabilities.